Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Circulation Research|June 4, 2026
Adipose Tissue Plasticity, Lipoprotein Metabolism, and Cardiovascular Risk: The Emerging Role of the GLP-1 AxisGiuliana G Repetti, E Dale Abel, Peter Tontonoz, et al.Circulation Research|May 24, 2019
Novel Therapies for Prevention and Early Treatment of CardiomyopathiesGiuliana G Repetti, Christopher N Toepfer, Jonathan G Seidman, et al.Current Opinion in Cardiology|March 26, 2026
Genetic factors contributing to atherosclerosisMichael A Raddatz, Hooman Allayee, Aldons J LusisAmerican Journal of Physiology. Heart and Circulatory Physiology|May 4, 2019
Adaptive immune cells in calcific aortic valve diseaseMichael A Raddatz, Meena S Madhur, W David MerrymanChest|December 9, 2022
A 77-Year-Old Woman With Capillary Hypoxia and Perioral CyanosisDaniel Z Hodson, Giuliana G Repetti, Daniel T Hoesterey, et al.Cardiology Clinics|November 17, 2024
Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular HealthMichael A Raddatz, Yash Pershad, Alyssa C Parker, et al.Stem Cells International|August 3, 2021
Epicardially Placed Bioengineered Cardiomyocyte Xenograft in Immune-Competent Rat Model of Heart FailureIkeotunye Royal Chinyere, Pierce Bradley, Joshua Uhlorn, et al.The Annals of Thoracic Surgery|May 11, 2019
Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch in Rats With Heart FailureJordan J Lancaster, Pablo Sanchez, Giuliana G Repetti, et al.JACC. Basic to Translational Science|May 8, 2019
Celecoxib Is Associated With Dystrophic Calcification and Aortic Valve StenosisMeghan A Bowler, Michael A Raddatz, Camryn L Johnson, et al.Scientific Reports|December 28, 2022
Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathyFrancesca Margara, Yiangos Psaras, Zhinuo Jenny Wang, et al.Pageof 3